OVID THERAPEUTICS INC's ticker is OVID and the CUSIP is 690469101. A total of 51 filers reported holding OVID THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $548,576 | +17.1% | 142,858 | +0.0% | 0.00% | – |
| Q2 2023 | $468,509 | +27.1% | 142,838 | 0.0% | 0.00% | – |
| Q1 2023 | $368,522 | +549932.8% | 142,838 | +300.1% | 0.00% | – |
| Q4 2022 | $67 | -99.9% | 35,704 | -14.4% | 0.00% | – |
| Q3 2022 | $77,000 | +26.2% | 41,720 | +113.2% | 0.00% | – |
| Q1 2022 | $61,000 | -3.2% | 19,564 | 0.0% | 0.00% | – |
| Q4 2021 | $63,000 | -79.2% | 19,564 | -63.0% | 0.00% | – |
| Q3 2020 | $303,000 | -22.1% | 52,819 | 0.0% | 0.00% | – |
| Q2 2020 | $389,000 | +111.4% | 52,819 | -14.5% | 0.00% | – |
| Q1 2020 | $184,000 | -51.1% | 61,794 | -31.9% | 0.00% | – |
| Q4 2019 | $376,000 | +27.9% | 90,701 | 0.0% | 0.00% | – |
| Q3 2019 | $294,000 | +75.0% | 90,701 | 0.0% | 0.00% | – |
| Q2 2019 | $168,000 | +4.3% | 90,701 | 0.0% | 0.00% | – |
| Q1 2019 | $161,000 | -23.7% | 90,701 | +3.9% | 0.00% | – |
| Q4 2018 | $211,000 | -52.5% | 87,257 | +11.5% | 0.00% | – |
| Q3 2018 | $444,000 | – | 78,262 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AWH Capital, L.P. | 230,000 | $407,000 | 0.69% |
| BVF INC/IL | 3,293,000 | $5,829,000 | 0.65% |
| COWEN INC. | 1,101,414 | $1,950,000 | 0.21% |
| ARMISTICE CAPITAL, LLC | 1,780,000 | $3,151,000 | 0.17% |
| Granite Point Capital Management, L.P. | 417,857 | $740,000 | 0.07% |
| Redmile Group, LLC | 737,550 | $1,305,000 | 0.04% |
| Tekla Capital Management LLC | 496,977 | $880,000 | 0.04% |
| Fairpointe Capital LLC | 101,000 | $179,000 | 0.01% |
| Alyeska Investment Group, L.P. | 225,000 | $398,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 84,440 | $149,000 | 0.00% |